Yuki Domon

Binding Characteristics and Analgesic Effects of Mirogabalin, a Novel Ligand for the α2δ Subunit of Voltage-Gated Calcium Channels

Yuki Domon, Naohisa Arakawa, Tatsuya Inoue et al. · Journal of Pharmacology and Experimental Therapeutics · 2018 · 148 citations · Full text

Infantile Pain Episodes Associated with Novel Nav1.9 Mutations in Familial Episodic Pain Syndrome in Japanese Families

Hiroko Okuda, Atsuko Noguchi, Hatasu Kobayashi et al. · PLoS ONE · 2016 · 51 citations · Full text

Analgesic effects of mirogabalin, a novel ligand for α2δ subunit of voltage-gated calcium channels, in experimental animal models of fibromyalgia

Kensuke Saeki, Shun-ichi Yasuda, Masami Kato et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 2019 · 28 citations

Pain Disorders, Molecular Physiology, Health Sciences +15

Discovery of DS-1971a, a Potent, Selective Na_V1.7 Inhibitor

Tsuyoshi Shinozuka, Hiroyuki Kobayashi, Sayaka Suzuki et al. · Journal of Medicinal Chemistry · 2020 · 20 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Pharmaceutical Science +15

Anxiolytic-like effects of mirogabalin, a novel ligand for α2δ ligand of voltage-gated calcium channels, in rats repeatedly injected with acidic saline intramuscularly, as an experimental model of fibromyalgia

Hiroyasu Murasawa, Hiroyuki Kobayashi, Shun-ichi Yasuda et al. · Pharmacological Reports · 2020 · 14 citations

Pain Disorders, Pain Medicine, Synaptic Transmission +19